EGFR and pancreatic neoplasm: Furthermore, preincubating pancreatic cancer cells that overexpress EGFR, such as AsPC-1, with C225 significantly reduces the uptake of ACG44 nanoconjugates, while the uptake of AIG44 remains unaffected.